WHO ICTRP trial
Effect of synbiotic supplement on placental uterine blood flow in patients with…
IRCT20191104045328N17 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20191104045328N17 |
|---|---|
| Public title | Effect of synbiotic supplement on placental uterine blood flow in patients with polycystic ovary syndrome |
| Scientific title | The effect of synbiotic supplementation on placental uterine blood flow, lipid profile and glycemic index in pregnant women with polycystic ovary syndrome |
| Primary sponsor | Arak University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Polycystic ovary syndrome. Polycystic ovarian syndrome;E28.2 |
| Interventions | Intervention 1: Intervention group: In the intervention group, patients will take one supplement capsule of Synbiotic Lactofem from Zisttakhmir company daily from the 28th week of pregnancy until the end of the 37th week. Intervention 2… |
| Registration date | Oct 2, 2023 |
| Target size | 98 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: